Kymera reports positive KT-579 Phase 1 data, updates KT-621 and cash runway
Lupus trial for KT-579 set to start by early 2027 as Kymera reports topline AD data from KT-621 due by year-end 2026 and $1.6 billion cash into 2029.
SEC filing
3 stories
Lupus trial for KT-579 set to start by early 2027 as Kymera reports topline AD data from KT-621 due by year-end 2026 and $1.6 billion cash into 2029.
SEC filing